Patients using GLP-1 drugs for obesity and type 2 diabetes may have a slightly higher chance of developing hair loss, according to three new studies.
GSK has received Early FDA Approval for its new lung cancer drug, Jideytro. The decision marks a major milestone for the company as it enters the competitive market for targeted lung cancer therapies.
The 6th Edition Drug Safety Symposium 2026 – India Chapter, organized by Eminence Business Media, concluded successfully in Mumbai, reaffirming its position as one of India's leading knowledge
The Congo Ebola Crisis has entered another critical phase. The outbreak has now recorded 2,473 confirmed cases and 999 deaths. The latest figures mark a sharp rise from previous updates.
Dr Reddy's API fix has cleared the way for the return of generic semaglutide supplies by November. The company expects production to resume after resolving a quality issue linked to the active pharmaceutical ingredient.
The Prostate Cancer Treatment from Pfizer has taken a major step toward expanded use in the US. The company has received FDA Priority Review for its supplemental New Drug Application. The application seeks approval for Talzenna in combination...
Novartis posted stronger Q2 sales, helped by robust demand for its blockbuster medicines. The Swiss drugmaker also maintained its full-year 2026 outlook.
Intas Pharmaceuticals has achieved a major milestone in India's breast cancer drug market. The company has received CDSCO approval to market its Trastuzumab Emtansine biosimilar in India.
A new Weekly HIV Pill could change how people manage HIV. Gilead Sciences and Merck reported positive results from two late-stage studies.
A fresh Trump tariff warning dragged pharma stocks lower on Tuesday. Investors turned cautious after Donald Trump proposed steep duties on imported generic drugs.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")